+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

A step toward development of printable dosage forms for poorly soluble drugs

A step toward development of printable dosage forms for poorly soluble drugs

Journal of Pharmaceutical Sciences 102(10): 3694-3704

The purpose of this study was to formulate printable dosage forms for a poorly soluble drug (piroxicam; PRX) and to gain understanding of critical parameters to be considered during development of such dosage forms. Liquid formulations of PRX were printed on edible paper using piezoelectric inkjet printing (PIJ) and impression printing (flexography). The printed dosage forms were characterized using scanning electron microscopy with energy dispersive X-ray spectroscopy (SEMa EDX) and the amount of drug was determined using high-performance liquid chromatography. Solutions of PRX in polyethylene glycol 400 (PEG-400):ethanol (40:60) and in PEG-400 were found to be optimal formulations for PIJ and flexography, respectively. SEMa EDX analysis revealed no visible solid particles on the printed dosage forms indicating the drug most likely remained in solution after printing. More accurate drug deposition was obtained by PIJ as compared with flexography. More than 90% drug release was achieved within 5 min regardless of printing method used. The solubility of drug in solvents/cosolvents, rheological properties of formulations, properties of substrate, feasibility and accuracy of the printing methods, and detection limit of analytical techniques for characterization of printed dosage forms are some of the concerns that need to be addressed for development of printable dosage forms of poorly soluble drugs.

(PDF emailed within 0-6 h: $19.90)

Accession: 037205315

Download citation: RISBibTeXText

PMID: 23904182

DOI: 10.1002/jps.23678

Related references

Designing novel oral solid dosage forms for poorly water soluble drugs. Pharmaceutical Research (New York) 13(9 SUPPL ): S215, 1996

Development of clinical dosage forms for a poorly water-soluble drug II: formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug. Journal of Pharmaceutical Sciences 98(5): 1750-1764, 2008

Combining inkjet printing and amorphous nanonization to prepare personalized dosage forms of poorly-soluble drugs. European Journal of Pharmaceutics and Biopharmaceutics 96: 314-321, 2016

In vitro tools for evaluating novel dosage forms of poorly soluble, weakly basic drugs: case example ketoconazole. Journal of Pharmaceutical Sciences 102(10): 3645-3652, 2014

Mesoporous silica-based dosage forms improve release characteristics of poorly soluble drugs: case example fenofibrate. Journal of Pharmacy and Pharmacology 68(5): 634-645, 2015

Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test. European Journal of Pharmaceutics and Biopharmaceutics 76(1): 105-111, 2010

Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system. Journal of Pharmaceutical Sciences 93(5): 1165-1175, 2004

The potential use of hydrosols as a new intravenous dosage form for poorly water soluble drugs. Acta Pharmaceutica Technologica 36(1): 21S, 1990

Using biorelevant dissolution to obtain IVIVC of solid dosage forms containing a poorly-soluble model compound. European Journal of Pharmaceutics and Biopharmaceutics 69(2): 648-657, 2008

In-line high-pressure particle size reduction of poorly soluble drugs to enhance oral bio-availability of drugs delivered by freeze dried fast dispersing dosage form. Journal of Pharmacy & Pharmacology 55(Supplement): S 63-S 64, September, 2003

Supersaturation-nucleation behavior of poorly soluble drugs and its impact on the oral absorption of drugs in thermodynamically high-energy forms. Journal of Pharmaceutical Sciences 101(1): 214-222, 2012

Development of a oral dosage form of poorly water soluble NSC 629243, an anti-HIV compound. Pharmaceutical Research (New York) 11(10 SUPPL ): S138, 1994

Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. Advanced Drug Delivery Reviews 64(6): 480-495, 2012

Controlled release dosage forms containing water soluble drugs. Official Gazette of the United States Patent & Trademark Office Patents 1217(4): 3285, Dec 22, 1998

One-step preparation of drug-containing microparticles to enhance the dissolution and absorption of poorly water-soluble drugs using a 4-fluid nozzle spray drier. Journal of Controlled Release 120(3): 205-210, 2007